BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 12626718)

  • 1. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties.
    Fraga MF; Ballestar E; Montoya G; Taysavang P; Wade PA; Esteller M
    Nucleic Acids Res; 2003 Mar; 31(6):1765-74. PubMed ID: 12626718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-dependent and -independent genomic targeting principles of the MBD protein family.
    Baubec T; Ivánek R; Lienert F; Schübeler D
    Cell; 2013 Apr; 153(2):480-92. PubMed ID: 23582333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenopus MBD3 plays a crucial role in an early stage of development.
    Iwano H; Nakamura M; Tajima S
    Dev Biol; 2004 Apr; 268(2):416-28. PubMed ID: 15063177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.
    Fujita N; Shimotake N; Ohki I; Chiba T; Saya H; Shirakawa M; Nakao M
    Mol Cell Biol; 2000 Jul; 20(14):5107-18. PubMed ID: 10866667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
    Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
    Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The solution structure of the domain from MeCP2 that binds to methylated DNA.
    Wakefield RI; Smith BO; Nan X; Free A; Soteriou A; Uhrin D; Bird AP; Barlow PN
    J Mol Biol; 1999 Sep; 291(5):1055-65. PubMed ID: 10518942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.
    Jiang CL; Jin SG; Lee DH; Lan ZJ; Xu X; O'Connor TR; Szabó PE; Mann JR; Cooney AJ; Pfeifer GP
    Genomics; 2002 Dec; 80(6):621-9. PubMed ID: 12504854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analyses reveal that MBD3 is a methylated CG binder.
    Liu K; Lei M; Wu Z; Gan B; Cheng H; Li Y; Min J
    FEBS J; 2019 Aug; 286(16):3240-3254. PubMed ID: 30980593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides.
    Daniel JM; Spring CM; Crawford HC; Reynolds AB; Baig A
    Nucleic Acids Res; 2002 Jul; 30(13):2911-9. PubMed ID: 12087177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of binding stoichiometry and recognition specificity for the interaction of MBD2b protein and methylated DNA revealed by affinity capillary electrophoresis coupled with laser-induced fluorescence analysis.
    Zou D; Zhang D; Liu S; Zhao B; Wang H
    Anal Chem; 2014 Feb; 86(3):1775-82. PubMed ID: 24422445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S; Oishi M
    Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.
    El-Osta A; Baker EK; Wolffe AP
    Mol Biol Rep; 2001; 28(4):209-15. PubMed ID: 12153140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
    Nan X; Meehan RR; Bird A
    Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional repression by Drosophila methyl-CpG-binding proteins.
    Roder K; Hung MS; Lee TL; Lin TY; Xiao H; Isobe KI; Juang JL; Shen CJ
    Mol Cell Biol; 2000 Oct; 20(19):7401-9. PubMed ID: 10982856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.